LSL Pharma Group Inc. (TSXV:LSL)
Canada
· Delayed Price · Currency is CAD 0.410
+0.005 (1.23%)
Mar 9, 2026, 10:50 AM EST
LSL Pharma Group Revenue
LSL Pharma Group had revenue of 7.58M CAD in the quarter ending September 30, 2025, with 88.97% growth. This brings the company's revenue in the last twelve months to 26.80M, up 69.41% year-over-year. In the year 2024, LSL Pharma Group had annual revenue of 17.75M with 76.98% growth.
Revenue (ttm)
26.80M
Revenue Growth
+69.41%
P/S Ratio
1.83
Revenue / Employee
144.11K
Employees
186
Market Cap
49.09M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ZYUS Life Sciences | 465.00K |
| C21 Investments | 45.62M |
| Leef Brands | 45.21M |
| Vext Science | 66.63M |
| iAnthus Capital Holdings | 209.79M |
| Decibel Cannabis Company | 109.31M |
| BioNxt Solutions | 15.82K |
| Rubicon Organics | 57.19M |